Dynavax Technologies Corporation - Company & Market Research Reports

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.


Systemic Lupus Erythematosus Market: By Therapies, Corticosteroids Cytotoxic & Immunosuppressive Drugs, Biologics, Small Molecules & By Region - Forecast 2016-2021 - Product Thumbnail Image

Systemic Lupus Erythematosus Market: By Therapies, Corticosteroids Cytotoxic & Immunosuppressive Drugs, Biologics, Small Molecules & By Region - Forecast 2016-2021

  • Report
  • 136 Pages
From
Hepatitis Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2017

  • Report
  • 209 Pages
From
Global Bronchodilators Market 2017-2021 - Product Thumbnail Image

Global Bronchodilators Market 2017-2021

  • Report
  • 83 Pages
From
Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Product Thumbnail Image

Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020

  • Report
  • 87 Pages
From
Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth - Product Thumbnail Image

Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth

  • Report
  • 72 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
Global Hepatitis B Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Hepatitis B Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Global Human Vaccines Market - Technologies, Market share and Industry Forecast to 2024 - Product Thumbnail Image

Global Human Vaccines Market - Technologies, Market share and Industry Forecast to 2024

  • Report
  • 240 Pages
From
Global Travel Vaccines Market 2016-2020 - Product Thumbnail Image

Global Travel Vaccines Market 2016-2020

  • Report
  • 60 Pages
From
Global Human Vaccine Market 2016-2020 - Product Thumbnail Image

Global Human Vaccine Market 2016-2020

  • Report
  • 111 Pages
From
DNA Vaccines Market: By Type, By Therapeutic Category & By Region - Forecast 2016-2021 - Product Thumbnail Image

DNA Vaccines Market: By Type, By Therapeutic Category & By Region - Forecast 2016-2021

  • Report
  • 143 Pages
From
Dynavax's HEPLISAV - a hepatitis B vaccine with a first-in-class adjuvant - Product Thumbnail Image

Dynavax's HEPLISAV - a hepatitis B vaccine with a first-in-class adjuvant

  • Report
  • 39 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H2 2017

  • Report
  • 2678 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2017

  • Report
  • 2437 Pages
From
Pancreatitis - Pipeline Insight, 2018 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Autoimmune Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Disease Therapeutics - Global Strategic Business Report

  • Report
  • 749 Pages
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Report
  • 1103 Pages
From
Anthrax - Pipeline Review, H1 2018 - Product Thumbnail Image

Anthrax - Pipeline Review, H1 2018

  • Report
  • 109 Pages
From
Anthrax - Pipeline Review, H2 2017 - Product Thumbnail Image

Anthrax - Pipeline Review, H2 2017

  • Report
  • 142 Pages
From
Loading Indicator
adroll